Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sturk

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Disability and Rehabilitation. Assistive Technology|December 26, 2017
Maintaining stable transfemoral amputee gait on level, sloped and simulated uneven conditions in a virtual environmentJames A Sturk, Edward D Lemaire, Emily H Sinitski, et al.
The Journal of Clinical Investigation|February 1, 1987
Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesisA Sturk, M C Schaap, J W ten Cate, et al.
Blood|December 15, 1990
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathwaysS J van Deventer, H R Büller, J W ten Cate, et al.
Thrombosis and Haemostasis|June 12, 1999
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactionsP W Kamphuisen, J C Eikenboom, H L Vos, et al.
Heart (British Cardiac Society)|March 1, 1996
Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarctionR J de Winter, R W Koster, J H Schotveld, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1987
Analytical and clinical evaluation of commercial protein C assaysA Sturk, W M Morrien-Salomons, M V Huisman, et al.
Thrombosis and Haemostasis|November 1, 1994
Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assaysM T Nurmohamed, R J Berckmans, W M Morriën-Salomons, et al.
American Journal of Obstetrics and Gynecology|February 1, 1997
Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion moleculesA Konijnenberg, E W Stokkers, J A van der Post, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 2005
Congenital deficiency of factor XIII caused by two missense mutations in a Dutch familyW Onland, A N Böing, A B Meijer, et al.
Thrombosis and Haemostasis|March 1, 1995
Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic feverM V Heller, R F Marta, A Sturk, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Disability and Rehabilitation. Assistive Technology|December 26, 2017
Maintaining stable transfemoral amputee gait on level, sloped and simulated uneven conditions in a virtual environmentJames A Sturk, Edward D Lemaire, Emily H Sinitski, et al.
The Journal of Clinical Investigation|February 1, 1987
Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesisA Sturk, M C Schaap, J W ten Cate, et al.
Blood|December 15, 1990
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathwaysS J van Deventer, H R Büller, J W ten Cate, et al.
Thrombosis and Haemostasis|June 12, 1999
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactionsP W Kamphuisen, J C Eikenboom, H L Vos, et al.
Heart (British Cardiac Society)|March 1, 1996
Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarctionR J de Winter, R W Koster, J H Schotveld, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1987
Analytical and clinical evaluation of commercial protein C assaysA Sturk, W M Morrien-Salomons, M V Huisman, et al.
Thrombosis and Haemostasis|November 1, 1994
Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assaysM T Nurmohamed, R J Berckmans, W M Morriën-Salomons, et al.
American Journal of Obstetrics and Gynecology|February 1, 1997
Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion moleculesA Konijnenberg, E W Stokkers, J A van der Post, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 2005
Congenital deficiency of factor XIII caused by two missense mutations in a Dutch familyW Onland, A N Böing, A B Meijer, et al.
Thrombosis and Haemostasis|March 1, 1995
Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic feverM V Heller, R F Marta, A Sturk, et al.
Pageof 16